Cardiovascular - South Austin
Treatment: Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
Participation: 26 office visits over 5 years
Compensation: Payment received after each completed office visit for a total of $1,400
Testosterone - Round Rock
Treatment: Testosterone Replacement Therapy
Participation: 17 office visits and 9 phone visits over 5 years
Compensation: Payment received after each completed office visit for a total of $1,270
Closed Loop Pump Study - Central Austin
Treatment: Demonstrate the safety and effectiveness of the Hybrid Closed Loop Pump in Type 1 Diabetics.
Participation: 13 office visits and 5 phone visits over 1 year.
Compensation: Payment received after each completed visit for a total of $725.00.
Glucose Sensor with Recording Devices - South Austin
Treatment: Collect data on the performance of sensor(s) each connected to the transmitter(s) during 11 or 15 days of wear (approximately 264 or 360 hours) in subjects with insulin requiring diabetes.
Participation: 11 to 15 days
Compensation: Payment received after each completed office visit for a total of $300
Type 2 Diabetes - South Austin
Treatment: Compare the efficacy of ORMD-0801 to placebo in improving glycemic control in T2DM subjects inadequately controlled on oral therapy based on HbA1C.
Participation: 12 visits over 15 weeks
Compensation: Payment received after each completed visit for a total of $675
Type 2 Diabetes - Central Austin
Treatment: Long acting insulin in study participants previously treated with basal insulin
Participation: 19 office visits and 4 phone visits over 37 weeks
Compensation: Payment received after each completed office visit for a total of $1,175
Type 2 Diabetes - Downtown Austin
Treatment: Once weekly insulin
Participation: 16 office visits and 14 phone visits over 31 weeks
Compensation: Payment received after each competed visit for a total of $1,225
Rapid Acting Insulin - South Austin
Treatment: The aim of this study is to demonstrate that an ultra-rapid formulation of insulin lispro is noninferior to Humalog on glycemic control
Participation: 12 office visits and 2 phone visits over 24 weeks
Compensation: Payment received after each completed visit for a total of $400
Rapid Acting Insulin - Round Rock
Treatment: The aim of this study is to demonstrate that an ultra-rapid formulation of insulin lispro is noninferior to Humalog on glycemic control
Participation: 12 office visits and 2 phone visits over 24 weeks
Compensation: Payment received after each completed visit for a total of $400
